90% of all start up companies biotech or not reports -O- income. Why would they have a revenue stream with no product? Once they have a marketable FDA approved product then they can attract big pharma to buy them out! I never heard of any start-up penny stock company making millions of dollars in revenue with no product!

There will be a drastic change in PPS this July as FDA response is expected to come any day now that will initiate clinical trials on humans.

Click on the link below to see why biotech companies need to dilute and what operating expenses they have?

http://www.dataev.com/it-experts-blog/bid/290...kimp-on-IT